Genotype-phenotype correlation over time in Angelman syndrome: Researching 134 patients
- PMID: 39169619
- PMCID: PMC11404063
- DOI: 10.1016/j.xhgg.2024.100342
Genotype-phenotype correlation over time in Angelman syndrome: Researching 134 patients
Abstract
Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by the loss of function of maternal UBE3A. The major cause of AS is a maternal deletion in 15q11.2-q13, and the minor causes are a UBE3A mutation, uniparental disomy (UPD), and imprinting defect (ID). Previous reports suggest that all patients with AS exhibit developmental delay, movement or balance disorders, behavioral characteristics, and speech impairment. In contrast, a substantial number of AS patients with a UBE3A mutation, UPD, or ID were reported not to show these consistent features and to show age-dependent changes in their features. In this study, we investigated 134 patients with AS, including 57 patients with a UBE3A mutation and 48 patients with UPD or ID. Although developmental delay was present in all patients, 20% of patients with AS caused by UPD or ID did not exhibit movement or balance disorders. Differences were also seen in hypopigmentation and seizures, depending on the causes. Moreover, patients with a UBE3A mutation, UPD, or ID tended to show fewer of the specific phenotypes depending on their age. In particular, in patients with UPD or ID, easily provoked laughter and hyperactivity tended to become more pronounced as they aged. Therefore, the clinical features of AS based on cause and age should be understood, and genetic testing should not be limited to patients with the typical clinical features of AS.
Keywords: UBE3A; epigenetics; imprinting defect; uniparental disomy.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Figures


Similar articles
-
Distinct phenotypes distinguish the molecular classes of Angelman syndrome.J Med Genet. 2001 Dec;38(12):834-45. doi: 10.1136/jmg.38.12.834. J Med Genet. 2001. PMID: 11748306 Free PMC article.
-
Increased body mass in infancy and early toddlerhood in Angelman syndrome patients with uniparental disomy and imprinting center defects.Am J Med Genet A. 2015 Jan;167A(1):142-6. doi: 10.1002/ajmg.a.36831. Epub 2014 Nov 17. Am J Med Genet A. 2015. PMID: 25402239
-
Screening of UBE3A gene in patients referred for Angelman Syndrome.Eur J Paediatr Neurol. 2013 Jul;17(4):366-73. doi: 10.1016/j.ejpn.2012.12.010. Epub 2013 Feb 14. Eur J Paediatr Neurol. 2013. PMID: 23416059
-
Genotype-Phenotype Correlations in Angelman Syndrome.Genes (Basel). 2021 Jun 28;12(7):987. doi: 10.3390/genes12070987. Genes (Basel). 2021. PMID: 34203304 Free PMC article. Review.
-
Molecular epigenetics of Angelman syndrome.Cell Mol Life Sci. 2007 Apr;64(7-8):947-60. doi: 10.1007/s00018-007-6460-0. Cell Mol Life Sci. 2007. PMID: 17347796 Free PMC article. Review.
Cited by
-
Diagnosis of Angelman Syndrome, With 66 Years of Delay, Using Hypothesis-Free DNA Methylation Profiling.Clin Genet. 2025 Jun 15;108(3):369-70. doi: 10.1111/cge.70000. Online ahead of print. Clin Genet. 2025. PMID: 40518603 Free PMC article.
References
-
- Jiang Y.H., Armstrong D., Albrecht U., Atkins C.M., Noebels J.L., Eichele G., Sweatt J.D., Beaudet A.L. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron. 1998;21:799–811. doi: 10.1016/s0896-6273(00)80596-6. - DOI - PubMed
-
- Sutcliffe J.S., Jiang Y.H., Galijaard R.J., Matsuura T., Fang P., Kubota T., Christian S.L., Bressler J., Cattanach B., Ledbetter D.H., Beaudet A.L. The E6-Ap ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region. Genome Res. 1997;7:368–377. doi: 10.1101/gr.7.4.368. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials